4front Ventures CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
4Front Ventures Corp. announced that its U.S. subsidiaries have entered voluntary receivership, leading to the resignation of two key board members, Kris Krane and David Daily.
OTC.Pink
4Front Ventures Corp. has announced its assignment into bankruptcy proceedings under the Canadian Bankruptcy and Insolvency Act, with a trustee appointed to manage its assets.
OTC.Pink
4Front Ventures Corp. has been delisted from the OTCQB Venture Market and commenced trading on the OTC Pink Market effective May 19, 2025, following its failure to file audited financial statements for the year ended December 31, 2024.
OTC.Pink
4Front Ventures Corp. announced that all its U.S. subsidiaries have filed for voluntary receivership in Massachusetts due to significant liabilities and a lack of available financing, anticipating delisting from Canadian and OTC markets.
OTC.Pink
Michael Kronberg voluntarily resigned as Interim Chief Financial Officer of 4Front Ventures Corp., effective May 12, 2025, and will remain with the company as Director, Finance.
OTC.Pink
4Front Ventures Corp. received a cease trade order from the Ontario Securities Commission due to its failure to file required financial documents.
OTC.Pink
4Front Ventures' application for a management cease trade order (MCTO) was denied by the Ontario Securities Commission (OSC), leading to an impending failure-to-file cease trade order (FFCTO) due to a delay in filing its annual financial statements.
OTC.Pink
4Front Ventures Corp. announces a delay in filing its annual financial statements due to financial constraints and has applied for a management cease trade order.
OTC.Pink
4Front Ventures announces board resignations, RSU issuance to directors in lieu of cash, and a delay in filing its 2024 audited financials due to ongoing financing and restructuring efforts.
OTC.Pink
Three directors, Chetan Gulati, Leo Gontmakher, and Roman Tkachenko, resigned from the Board of Directors of 4Front Ventures Corp. effective March 29, 2025.
OTC.Pink
4Front Ventures announced its Q3 2024 results, showcasing revenue of $17.1 million and adjusted EBITDA of $1.0 million, with significant progress in Illinois and Massachusetts.
OTC.Pink
4Front Ventures will release its third quarter 2024 financial results on November 14th, followed by a conference call to discuss the results and provide a business update.
OTC.Pink
4Front Ventures has officially opened its 250,000 sq. ft. cultivation and production facility in Matteson, Illinois, marking a significant expansion in the state's cannabis market.
OTC.Pink
4Front Ventures Corp. held its annual meeting on October 18, 2024, where shareholders approved the election of directors, the appointment of an auditor, and a restricted equity plan.
OTC.Pink
4Front Ventures has announced the departure of its CFO, Peter Kampian, as part of a restructuring effort, with Michael Kronberg stepping in as Interim CFO.
OTC.Pink
4Front Ventures Corp. reports the voluntary resignation of its Chief Financial Officer, Peter Kampian, and the appointment of Michael Kronberg as interim CFO, effective October 23, 2024.
OTC.Pink
4Front Ventures has engaged Canaccord Genuity to explore refinancing and growth capital options, while also amending its credit facility and issuing restricted stock units.
OTC.Pink
4Front Ventures reported Q2 2024 revenue of $18.7 million and adjusted EBITDA of $2.6 million, highlighting strong wholesale growth in Massachusetts and Illinois and the opening of a new facility in Illinois.
OTC.Pink
4Front Ventures will release its second quarter 2024 financial results on August 14th, followed by a conference call to discuss the results and provide a business update.
OTC.Pink
4Front Ventures has introduced Smoke Breaks, a new line of mini pre-rolled cannabis products, in Illinois and Massachusetts.
OTC.Pink
4Front Ventures has withdrawn its previously announced brokered offering and appointed Kris Krane as the new Board Chair, replacing Robert Hunt.
OTC.Pink
4Front Ventures announces the opening of a new Mission Dispensary in Norridge, Illinois, marking a significant expansion of its retail presence in the state.
OTC.Pink
4Front Ventures announced its Q1 2024 results, including $18.8 million in revenue and $2.5 million in adjusted EBITDA, alongside a significant debt conversion and progress on facility expansions.
OTC.Pink
4Front Ventures Corp. will release its first quarter 2024 financial results on May 17, 2024, and host a conference call to discuss the results.
OTC.Pink
4Front Ventures has announced the issuance of shares, restricted share units, and warrants to settle obligations and compensate consultants, directors, and officers.
OTC.Pink
4Front Ventures reported a decrease in revenue for 2023, but highlighted significant wholesale growth in key markets and strategic expansion plans.
OTC.Pink
4Front Ventures will release its fourth quarter and full year 2023 financial results on April 15, 2024, followed by a conference call to discuss the results.
OTC.Pink
4Front Ventures is expanding its Illinois operations with a new dispensary in Norridge and progress at its Matteson facility, while also launching its Crystal Clear Blast vape product in Massachusetts and Illinois.
OTC.Pink
4Front Ventures has introduced Mission Cannabis, a new premium flower brand, now available in Massachusetts and soon to be in Illinois, aiming to cater to diverse consumer preferences.
OTC.Pink
4Front Ventures has powered up its 250,000 sq ft cultivation and manufacturing facility in Matteson, Illinois, and is set to open a third retail dispensary in Norridge by the end of the quarter.